Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4594332

DONISLECEL
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available

Basic Information

ChEMBL ID CHEMBL4594332
Name DONISLECEL
Phase Approved
Structure Type NONE
Therapeutic ✓ Yes

Known Names

Donislecel Lantidra
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
2
Known Names
2
Indications
1
Mechanisms

Drug Information

Molecule Type Cell
First Approval 2023
Availability Unknown
Chirality Single Enantiomer
USAN Year 2019

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Somatic cell supplemental therapy - -

Indications

Hypoglycemia Diabetes Mellitus, Type 1

ATC Classification

A10XX02
donislecel
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS USED IN DIABETES

Data from ChEMBL 36 via Core Engine